ProShare Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-10,081
| Closed | -$98K | – | 1436 |
|
|
2017
Q2 | $98K | Sell |
10,081
-552
| -5% | -$5.37K | ﹤0.01% | 1401 |
|
|
2017
Q1 | $258K | Sell |
10,633
-2,742
| -21% | -$66.5K | ﹤0.01% | 1315 |
|
|
2016
Q4 | $429K | Buy |
13,375
+1,493
| +13% | +$47.9K | ﹤0.01% | 1155 |
|
|
2016
Q3 | $594K | Sell |
11,882
-2,100
| -15% | -$105K | 0.01% | 884 |
|
|
2016
Q2 | $593K | Buy |
13,982
+1,265
| +10% | +$53.7K | 0.01% | 896 |
|
|
2016
Q1 | $837K | Sell |
12,717
-1,235
| -9% | -$81.3K | 0.01% | 772 |
|
|
2015
Q4 | $867K | Buy |
13,952
+1,817
| +15% | +$113K | 0.01% | 803 |
|
|
2015
Q3 | $813K | Sell |
12,135
-803
| -6% | -$53.8K | 0.01% | 744 |
|
|
2015
Q2 | $1.26M | Sell |
12,938
-424
| -3% | -$41.3K | 0.02% | 668 |
|
|
2015
Q1 | $1.25M | Buy |
13,362
+1,773
| +15% | +$166K | 0.01% | 737 |
|
|
2014
Q4 | $1.03M | Sell |
11,589
-214
| -2% | -$19K | 0.01% | 834 |
|
|
2014
Q3 | $815K | Sell |
11,803
-2,253
| -16% | -$156K | 0.01% | 1147 |
|
|
2014
Q2 | $806K | Sell |
14,056
-8,355
| -37% | -$479K | 0.01% | 1268 |
|
|
2014
Q1 | $889K | Buy |
22,411
+15,787
| +238% | +$626K | 0.01% | 1398 |
|
|
2013
Q4 | $278K | Sell |
6,624
-5,697
| -46% | -$239K | ﹤0.01% | 1185 |
|
|
2013
Q3 | $368K | Buy |
12,321
+8,735
| +244% | +$261K | 0.01% | 1730 |
|
|
2013
Q2 | $190K | Buy |
+3,586
| New | +$190K | ﹤0.01% | 2061 |
|